The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...

When it first develops, emphysema, one of a group of lung diseases known as chronic obstructive pulmonary disease (COPD), is usually asymptomatic. As the illness progresses, however, it causes ...

Lung biopsy is a relatively frequently performed procedure with considerable benefit for patient management but it may, on rare occasions, result in the death of the patient. It is a multidisciplinary ...

The BSA requires banks to institute a written compliance program. The compliance program must include: Internal controls to ensure ongoing compliance. Procedures for independent testing.

Emphysema is not cancer. While emphysema and lung cancer are serious respiratory conditions, they are distinct conditions with different causes, treatments, and outcomes. However, the former can ...

Maternal exposure to PG/VG in mice reduces lung compliance in female offspring, highlighting potential sex-specific vulnerabilities. Flavoring agents, often perceived as harmless, can also exert ...

Impaired DLCO can be a key indicator of a decline in lung function and may link to emphysema in COPD. Emphysema is a type of COPD, where damage occurs to the alveoli and makes it more difficult ...

But what many people don’t realize is that the same low-dose CT scans used to screen for lung cancer can also uncover another life-threatening condition: Emphysema, a form of chronic obstructive ...

Pneumonia is a lung infection that can be caused by bacteria, viruses, or fungi. Pneumonia causes inflammation in the alveoli in one or both lungs. The inflamed alveoli fill with pus, which makes it ...

which have proposed as being critical to maintaining compliance in ASM (Bosse et al., 2013). Airway stiffness and progressive airway narrowing due to airway and/or parenchymal lung remodelling likely ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronically progressive interstitial lung that affects over 3 M people worldwide and rising in incidence. With a median survival of 2–3 years, IPF is ...